Lake S, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ Methadone dose, cannabis use, and treatment retention: findings from a community-based sample of people who use unregulated drugs J Addict Med, 2023. PubMed


Olding M, Boyd J, Kerr T, Fowler A, McNeil R (Re)situating expertise in community-based overdose response: insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada Int J Drug Policy, 2023. PubMed


Moallef S, DeBeck K, Fairbairn N, Cui Z, Brar R, Wilson D, Johnson C, Milloy MJ, Hayashi K Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy Addict Sci Clin Pract, 2022. PubMed


Coulaud Pj, Airagnes G, McGrath K, Bolduc N, Bertrand K, Jauffret-Roustide M, Knight R Factors associated with self-reported changes in alcohol use among young adults during the COVID-19 pandemic: a comparative analysis between Canada and France Int J Environ Res Public Health, 2022. PubMed


Bardwell G, Mansoor M, van Zwietering A, Cleveland E, Snell D, Kerr T The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting Harm Reduct J, 2022. PubMed


Moallef S, Genberg B, Hayashi K, Mehta S, Kirk G, Choi J, DeBeck K, Kipke M, Moore R, Baum M, Shoptaw S, Gorbach P, Mustanski B, Javanbakht M, Siminski S, Milloy MJ Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada Drug Alcohol Depend, 2022. PubMed


King L, Hayashi K, Genberg B, Choi J, DeBeck K, Kirk G, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Milloy MJ Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: data from the C3PNO Consortium Drug Alcohol Depend, 2022. PubMed


Cui Z, Bach P, Ti L, Hayashi K, Morgan J, Milloy MJ, Kerr T Opioid agonist therapy engagement and crystal methamphetamine use: the impact of unregulated opioid use in Vancouver, Canada Int J Drug Policy, 2022. PubMed


Gorbach PM, Rosen AD, Moore R, Shoptaw S, Mustanski B, Mehta SH, Kirk GD, Baum MK, Milloy MJ, Hayashi K, DeBeck K, Kipke M, Lai S, Siminski S, Javanbakht M Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV Drug Alcohol Depend, 2022. PubMed


Feder KA, Choi J, Schluth CG, Hayashi K, DeBeck K, Milloy MJ, Kirk GD, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Genberg BL Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada Drug Alcohol Depend, 2022. PubMed